We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Multiplex Nested PCR Detects Bloodstream Candida Species

By LabMedica International staff writers
Posted on 14 Aug 2014
A multiplex nested polymerase chain reaction (PCR) method has been developed to detect and identify seven Candida species in peripheral blood samples of critically ill pediatric patients.

Nosocomial candidaemia is associated with high mortality rates in critically ill pediatric and neonatal patients and therefore the early detection and identification of the infectious fungal agent is crucial for successful medical intervention.

Clinical microbiologists at the University of Sao Paulo (Butanta, Brazil) enrolled 54 consecutive pediatric patients, among whom there were 24 neonates, admitted to the intensive care unit (ICU) of two pediatric referral hospitals in Sao Paulo State (Brazil). More...
The patients presented with systemic inflammatory response syndrome (SIRS) and at least two predisposing conditions/risk factors for the development of candidaemia. A control group included 28 children that had no evidence of any type of bloodstream infection and had undergone minor surgical procedures during the same time.

Blood samples were taken and either cultured or had DNA extracted. The 54 DNA samples were evaluated by multiplex nested PCR with specific primers designed to identify seven Candida species, and the results were compared with those obtained from blood cultures.

The extracted DNA samples were amplified and the reactions were carried out in a Veriti thermocycler (Applied Biosystems; Carlsbad, CA, USA). The nested PCR products were detected on 2.5% agarose gels and visualized under a UV transilluminator apparatus (UVITEC; Cambridge, UK).

The multiplex nested PCR had a detection limit of four Candida genomes/mL of blood for all Candida species. Blood cultures were positive in 14.8% of patients, whereas the multiplex nested PCR was positive in 24.0% of patients, including all culture-positive patients. The results obtained with the molecular technique were available within 24 hours, and the assay was able to identify Candida species with 100% of concordance with blood cultures. Additionally the multiplex nested PCR detected dual candidaemia in three patients. Candida albicans was the most frequently isolated species in blood cultures (five out of eight positive results), while the multiplex nested PCR identified C. albicans, C. parapsilosis complex, and C. tropicalis at similar frequencies.

The authors concluded that multiplex PCR assay targeting the intergenic space region (ITS) of Candida ribosomal DNA was able to identify the main Candida species involved in bloodstream pediatric infections with a detection limit of less than 10 colony forming units (CFU)/mL. The assay had high specificity, and is as least as sensitive as blood cultures but with a shorter turnaround time. The use of the multiplex nested PCR method also allowed the detection and identification of one or more Candida species in the same reaction. The study was published on July 21, 2014, in the journal BMC Infectious Diseases.

Related Links:
University of Sao Paulo
Applied Biosystems
UVITEC



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Next-Generation Sequencing Platform
AXELIOS 1 Platform
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.